<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36823602</PMID><DateCompleted><Year>2023</Year><Month>02</Month><Day>27</Day></DateCompleted><DateRevised><Year>2023</Year><Month>02</Month><Day>28</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1742-2094</ISSN><JournalIssue CitedMedium="Internet"><Volume>20</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Feb</Month><Day>23</Day></PubDate></JournalIssue><Title>Journal of neuroinflammation</Title><ISOAbbreviation>J Neuroinflammation</ISOAbbreviation></Journal><ArticleTitle>Supporting the differential diagnosis of connective tissue diseases with neurological involvement by blood and cerebrospinal fluid flow cytometry.</ArticleTitle><Pagination><StartPage>46</StartPage><MedlinePgn>46</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">46</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12974-023-02733-w</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">Neurological manifestations of autoimmune connective tissue diseases (CTD) are poorly understood and difficult to diagnose. We here aimed to address this shortcoming by studying immune cell compositions in CTD patients with and without neurological manifestation.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Using flow cytometry, we retrospectively investigated paired cerebrospinal fluid (CSF) and blood samples of 28 CTD patients without neurological manifestation, 38 CTD patients with neurological manifestation (N-CTD), 38 non-inflammatory controls, and 38 multiple sclerosis (MS) patients, a paradigmatic primary neuroinflammatory disease.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">We detected an expansion of plasma cells in the blood of both N-CTD and CTD compared to non-inflammatory controls and MS. Blood plasma cells alone distinguished the clinically similar entities N-CTD and MS with high discriminatory performance (AUC: 0.81). Classical blood monocytes indicated higher disease activity in systemic lupus erythematosus (SLE) patients. Surprisingly, immune cells in the CSF did not differ significantly between N-CTD and CTD, while CD4<sup>+</sup> T cells and the CD4<sup>+</sup>/CD8<sup>+</sup> ratio were elevated in the blood of N-CTD compared to CTD. Several B cell-associated parameters partially overlapped in the CSF in MS and N-CTD. We built a machine learning model that distinguished N-CTD from MS with high discriminatory power using either blood or CSF.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">We here find that blood flow cytometry alone surprisingly suffices to distinguish CTD with neurological manifestations from clinically similar entities, suggesting that a rapid blood test could support clinicians in the differential diagnosis of N-CTD.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Heming</LastName><ForeName>Michael</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-9568-2790</Identifier><AffiliationInfo><Affiliation>Department of Neurology With Institute of Translational Neurology, University Hospital M&#xfc;nster, Albert-Schweitzer-Campus 1, Building A1, 48149, M&#xfc;nster, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>M&#xfc;ller-Miny</LastName><ForeName>Louisa</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0001-5689-585X</Identifier><AffiliationInfo><Affiliation>Department of Neurology With Institute of Translational Neurology, University Hospital M&#xfc;nster, Albert-Schweitzer-Campus 1, Building A1, 48149, M&#xfc;nster, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rolfes</LastName><ForeName>Leoni</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Neurology, University Hospital D&#xfc;sseldorf, D&#xfc;sseldorf, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schulte-Mecklenbeck</LastName><ForeName>Andreas</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-3855-4706</Identifier><AffiliationInfo><Affiliation>Department of Neurology With Institute of Translational Neurology, University Hospital M&#xfc;nster, Albert-Schweitzer-Campus 1, Building A1, 48149, M&#xfc;nster, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brix</LastName><ForeName>Tobias J</ForeName><Initials>TJ</Initials><AffiliationInfo><Affiliation>Institute of Medical Informatics, University of M&#xfc;nster, M&#xfc;nster, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Varghese</LastName><ForeName>Julian</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Institute of Medical Informatics, University of M&#xfc;nster, M&#xfc;nster, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pawlitzki</LastName><ForeName>Marc</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neurology, University Hospital D&#xfc;sseldorf, D&#xfc;sseldorf, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pavenst&#xe4;dt</LastName><ForeName>Hermann</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Division of General Internal Medicine, Nephrology and Rheumatology, Department of Medicine D, University Hospital of M&#xfc;nster, M&#xfc;nster, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kriegel</LastName><ForeName>Martin A</ForeName><Initials>MA</Initials><Identifier Source="ORCID">0000-0002-7371-0391</Identifier><AffiliationInfo><Affiliation>Department of Translational Rheumatology and Immunology, Institute of Musculoskeletal Medicine, University of M&#xfc;nster, M&#xfc;nster, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Section of Rheumatology and Clinical Immunology, Department of Medicine, University Hospital M&#xfc;nster, M&#xfc;nster, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gross</LastName><ForeName>Catharina C</ForeName><Initials>CC</Initials><Identifier Source="ORCID">0000-0002-4872-9189</Identifier><AffiliationInfo><Affiliation>Department of Neurology With Institute of Translational Neurology, University Hospital M&#xfc;nster, Albert-Schweitzer-Campus 1, Building A1, 48149, M&#xfc;nster, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wiendl</LastName><ForeName>Heinz</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0003-4310-3432</Identifier><AffiliationInfo><Affiliation>Department of Neurology With Institute of Translational Neurology, University Hospital M&#xfc;nster, Albert-Schweitzer-Campus 1, Building A1, 48149, M&#xfc;nster, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meyer Zu H&#xf6;rste</LastName><ForeName>Gerd</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0002-4341-4719</Identifier><AffiliationInfo><Affiliation>Department of Neurology With Institute of Translational Neurology, University Hospital M&#xfc;nster, Albert-Schweitzer-Campus 1, Building A1, 48149, M&#xfc;nster, Germany. gerd.mzh@uni-muenster.de.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>SEED/016/21</GrantID><Agency>Interdisziplin&#xe4;res Zentrum f&#xfc;r Klinische Forschung, M&#xfc;nster</Agency><Country/></Grant><Grant><GrantID>MzH3/020/030</GrantID><Agency>Interdisziplin&#xe4;res Zentrum f&#xfc;r Klinische Forschung, M&#xfc;nster</Agency><Country/></Grant><Grant><GrantID>HiGHmed 01ZZ1802V</GrantID><Agency>Bundesministerium f&#xfc;r Bildung und Forschung</Agency><Country/></Grant><Grant><GrantID>ME4050/12-1</GrantID><Agency>Deutsche Forschungsgemeinschaft</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>02</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Neuroinflammation</MedlineTA><NlmUniqueID>101222974</NlmUniqueID><ISSNLinking>1742-2094</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005434" MajorTopicYN="N">Flow Cytometry</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003937" MajorTopicYN="N">Diagnosis, Differential</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003240" MajorTopicYN="Y">Connective Tissue Diseases</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009103" MajorTopicYN="Y">Multiple Sclerosis</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Cerebrospinal fluid</Keyword><Keyword MajorTopicYN="N">Connective tissue disease</Keyword><Keyword MajorTopicYN="N">Flow cytometry</Keyword><Keyword MajorTopicYN="N">Systemic lupus erythematosus</Keyword></KeywordList><CoiStatement>A patent application covering the use of flow cytometry for diagnostic purposes of neurological involvement in rheumatic disorders has been requested by GMzH, MH, and HW. All the remaining authors have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>7</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>2</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>2</Month><Day>24</Day><Hour>0</Hour><Minute>51</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>2</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>3</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36823602</ArticleId><ArticleId IdType="pmc">PMC9951507</ArticleId><ArticleId IdType="doi">10.1186/s12974-023-02733-w</ArticleId><ArticleId IdType="pii">10.1186/s12974-023-02733-w</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ruff WE, Greiling TM, Kriegel MA. Host-microbiota interactions in immune-mediated diseases. Nat Rev Microbiol. 2020;18:521&#x2013;538. doi: 10.1038/s41579-020-0367-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-020-0367-2</ArticleId><ArticleId IdType="pubmed">32457482</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwartz N, Stock AD, Putterman C. Neuropsychiatric lupus: new mechanistic insights and future treatment directions. Nat Rev Rheumatol. 2019;15:137&#x2013;152. doi: 10.1038/s41584-018-0156-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41584-018-0156-8</ArticleId><ArticleId IdType="pmc">PMC8023338</ArticleId><ArticleId IdType="pubmed">30659245</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia LPW, Gladman DD, Urowitz M, et al. New EULAR/ACR 2019 SLE classification criteria: defining ominosity in SLE. Ann Rheum Dis. 2021;80:767&#x2013;774. doi: 10.1136/annrheumdis-2020-218670.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2020-218670</ArticleId><ArticleId IdType="pubmed">33452003</ArticleId></ArticleIdList></Reference><Reference><Citation>Govoni M, Hanly JG. The management of neuropsychiatric lupus in the 21st century: still so many unmet needs? Rheumatology. 2020;59:v52&#x2013;62. doi: 10.1093/rheumatology/keaa404.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/keaa404</ArticleId><ArticleId IdType="pmc">PMC7719041</ArticleId><ArticleId IdType="pubmed">33280014</ArticleId></ArticleIdList></Reference><Reference><Citation>Pavlakis PP, Alexopoulos H, Kosmidis ML, et al. Peripheral neuropathies in Sjogren syndrome: a new reappraisal. J Neurol Neurosurg Psychiatry. 2011;82:798&#x2013;802. doi: 10.1136/jnnp.2010.222109.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2010.222109</ArticleId><ArticleId IdType="pubmed">21172862</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishino H, Rubino FA, DeRemee RA, et al. Neurological involvement in Wegener&#x2019;s granulomatosis: an analysis of 324 consecutive patients at the Mayo clinic. Ann Neurol. 1993;33:4&#x2013;9. doi: 10.1002/ana.410330103.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.410330103</ArticleId><ArticleId IdType="pubmed">8388187</ArticleId></ArticleIdList></Reference><Reference><Citation>Mak A, Cheung MW-L, Chiew HJ, et al. Global trend of survival and damage of systemic lupus erythematosus: meta-analysis and meta-regression of observational studies from the 1950s to 2000s. Semin Arthritis Rheum. 2012;41:830&#x2013;839. doi: 10.1016/j.semarthrit.2011.11.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.semarthrit.2011.11.002</ArticleId><ArticleId IdType="pubmed">22257558</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanly JG, Urowitz MB, Gordon C, et al. Neuropsychiatric events in systemic lupus erythematosus: a longitudinal analysis of outcomes in an international inception cohort using a multistate model approach. Ann Rheum Dis. 2020;79:356&#x2013;362. doi: 10.1136/annrheumdis-2019-216150.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2019-216150</ArticleId><ArticleId IdType="pubmed">31915121</ArticleId></ArticleIdList></Reference><Reference><Citation>Carri&#xf3;n-Barber&#xe0; I, Salman-Monte TC, V&#xed;lchez-Oya F, et al. Neuropsychiatric involvement in systemic lupus erythematosus: a review. Autoimmun Rev. 2021;20:102780. doi: 10.1016/j.autrev.2021.102780.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2021.102780</ArticleId><ArticleId IdType="pubmed">33609799</ArticleId></ArticleIdList></Reference><Reference><Citation>Papachristos DA, Oon S, Hanly JG, et al. Management of inflammatory neurologic and psychiatric manifestations of systemic lupus erythematosus: a systematic review. Semin Arthritis Rheum. 2021;51:49&#x2013;71. doi: 10.1016/j.semarthrit.2020.12.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.semarthrit.2020.12.004</ArticleId><ArticleId IdType="pubmed">33360230</ArticleId></ArticleIdList></Reference><Reference><Citation>Aliaga ES, Barkhof F. MRI mimics of multiple sclerosis. Handb Clin Neurol. 2014;122:291&#x2013;316. 10.1016/B978-0-444-52001-2.00012-1.</Citation><ArticleIdList><ArticleId IdType="pubmed">24507523</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferreira S, D&#x2019;Cruz DP, Hughes GRV. Multiple sclerosis, neuropsychiatric lupus and antiphospholipid syndrome: where do we stand? Rheumatology. 2005;44:434&#x2013;442. doi: 10.1093/rheumatology/keh532.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/keh532</ArticleId><ArticleId IdType="pubmed">15644391</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo X, Piao S, Li H, et al. Multi-lesion radiomics model for discrimination of relapsing-remitting multiple sclerosis and neuropsychiatric systemic lupus erythematosus. Eur Radiol. 2022;32:5700&#x2013;5710. doi: 10.1007/s00330-022-08653-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00330-022-08653-2</ArticleId><ArticleId IdType="pubmed">35243524</ArticleId></ArticleIdList></Reference><Reference><Citation>Nikolopoulos D, Kitsos D, Papathanasiou M, et al. Demyelinating syndromes in systemic lupus erythematosus: data from the &#x201c;Attikon&#x201d; lupus cohort. Front Neurol. 2022;13:889613. doi: 10.3389/fneur.2022.889613.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2022.889613</ArticleId><ArticleId IdType="pmc">PMC9131105</ArticleId><ArticleId IdType="pubmed">35645967</ArticleId></ArticleIdList></Reference><Reference><Citation>Cojocaru IM, Socoliuc G, Sapira V, et al. Primary Sj&#xf6;gren&#x2019;s syndrome or multiple sclerosis? Our experience concerning the dilemma of clinically isolated syndrome. Rom J Intern Med. 2011;49:301&#x2013;318.</Citation><ArticleIdList><ArticleId IdType="pubmed">22568276</ArticleId></ArticleIdList></Reference><Reference><Citation>Maggi P, Absinta M, Sati P, et al. The &#x201c;central vein sign&#x201d; in patients with diagnostic &#x201c;red flags&#x201d; for multiple sclerosis: a prospective multicenter 3T study. Mult Scler. 2020;26:421&#x2013;432. doi: 10.1177/1352458519876031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1352458519876031</ArticleId><ArticleId IdType="pmc">PMC7080603</ArticleId><ArticleId IdType="pubmed">31536435</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson AJ, Baranzini SE, Geurts J, et al. Multiple sclerosis. Lancet. 2018;391:1622&#x2013;1636. doi: 10.1016/S0140-6736(18)30481-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(18)30481-1</ArticleId><ArticleId IdType="pubmed">29576504</ArticleId></ArticleIdList></Reference><Reference><Citation>Perez RK, Gordon MG, Subramaniam M, et al. Single-cell RNA-seq reveals cell type&#x2013;specific molecular and genetic associations to lupus. Science. 2022;376:eabf1970. doi: 10.1126/science.abf1970.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abf1970</ArticleId><ArticleId IdType="pmc">PMC9297655</ArticleId><ArticleId IdType="pubmed">35389781</ArticleId></ArticleIdList></Reference><Reference><Citation>George-Chandy A, Trysberg E, Eriksson K. Raised intrathecal levels of APRIL and BAFF in patients with systemic lupus erythematosus: relationship to neuropsychiatric symptoms. Arthritis Res Ther. 2008;10:R97. doi: 10.1186/ar2484.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/ar2484</ArticleId><ArticleId IdType="pmc">PMC2575611</ArticleId><ArticleId IdType="pubmed">18718031</ArticleId></ArticleIdList></Reference><Reference><Citation>Mok MY, Chan EYT, Wong WS, et al. Intrathecal immunoglobulin production in patients with systemic lupus erythematosus with neuropsychiatric manifestations. Ann Rheum Dis. 2007;66:846&#x2013;847. doi: 10.1136/ard.2006.061069.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/ard.2006.061069</ArticleId><ArticleId IdType="pmc">PMC1954662</ArticleId><ArticleId IdType="pubmed">17513577</ArticleId></ArticleIdList></Reference><Reference><Citation>Rubinstein TB, Putterman C, Goilav B. Biomarkers for CNS involvement in pediatric lupus. Biomark Med. 2015;9:545&#x2013;558. doi: 10.2217/bmm.15.26.</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/bmm.15.26</ArticleId><ArticleId IdType="pmc">PMC4641515</ArticleId><ArticleId IdType="pubmed">26079959</ArticleId></ArticleIdList></Reference><Reference><Citation>Karassa FB, Afeltra A, Ambrozic A, et al. Accuracy of anti-ribosomal P protein antibody testing for the diagnosis of neuropsychiatric systemic lupus erythematosus: an international meta-analysis. Arthritis Rheum. 2006;54:312&#x2013;324. doi: 10.1002/art.21539.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.21539</ArticleId><ArticleId IdType="pubmed">16385548</ArticleId></ArticleIdList></Reference><Reference><Citation>Heming M, Schulte-Mecklenbeck A, Brix T, et al. Immune cell profiling of the cerebrospinal fluid provides pathogenetic insights into inflammatory neuropathies. Front Immunol. 2019 doi: 10.3389/fimmu.2019.00515.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2019.00515</ArticleId><ArticleId IdType="pmc">PMC6448021</ArticleId><ArticleId IdType="pubmed">30984164</ArticleId></ArticleIdList></Reference><Reference><Citation>R&#xe4;uber S, Heming M, Repple J, et al. Cerebrospinal fluid flow cytometry distinguishes psychosis spectrum disorders from differential diagnoses. Mol Psychiatry. 2021;26:7661&#x2013;7670. doi: 10.1038/s41380-021-01244-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41380-021-01244-5</ArticleId><ArticleId IdType="pmc">PMC8873003</ArticleId><ArticleId IdType="pubmed">34363013</ArticleId></ArticleIdList></Reference><Reference><Citation>Heming M, Lohmann L, Schulte-Mecklenbeck A, et al. Leukocyte profiles in blood and CSF distinguish neurosarcoidosis from multiple sclerosis. J Neuroimmunol. 2020 doi: 10.1016/j.jneuroim.2020.577171.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jneuroim.2020.577171</ArticleId><ArticleId IdType="pubmed">32007787</ArticleId></ArticleIdList></Reference><Reference><Citation>Heming M, B&#xf6;rsch A-L, Wiendl H, et al. High-dimensional investigation of the cerebrospinal fluid to explore and monitor CNS immune responses. Genome Med. 2022;14:94. doi: 10.1186/s13073-022-01097-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13073-022-01097-9</ArticleId><ArticleId IdType="pmc">PMC9385102</ArticleId><ArticleId IdType="pubmed">35978442</ArticleId></ArticleIdList></Reference><Reference><Citation>Aringer M, Costenbader K, Daikh D, et al. 2019 European league against rheumatism/American college of rheumatology classification criteria for systemic lupus erythematosus. Arthritis Rheumatol. 2019;71:1400&#x2013;1412. doi: 10.1002/art.40930.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.40930</ArticleId><ArticleId IdType="pmc">PMC6827566</ArticleId><ArticleId IdType="pubmed">31385462</ArticleId></ArticleIdList></Reference><Reference><Citation>Shiboski CH, Shiboski SC, Seror R, et al. 2016 American College of rheumatology/european league against rheumatism classification criteria for primary sj&#xf6;gren&#x2019;s syndrome: a consensus and data-driven methodology involving three international patient cohorts. Arthritis Rheumatol. 2017;69:35&#x2013;45. doi: 10.1002/art.39859.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.39859</ArticleId><ArticleId IdType="pmc">PMC5650478</ArticleId><ArticleId IdType="pubmed">27785888</ArticleId></ArticleIdList></Reference><Reference><Citation>Robson JC, Grayson PC, Ponte C, et al. 2022 American college of rheumatology/European alliance of associations for rheumatology classification criteria for granulomatosis with polyangiitis. Arthritis Rheumatol. 2022;74:393&#x2013;399. doi: 10.1002/art.41986.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.41986</ArticleId><ArticleId IdType="pubmed">35106964</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho D, Imai K, King G, et al. MatchIt: nonparametric preprocessing for parametric causal inference. J Stat Soft. 2011;42:1&#x2013;28. doi: 10.18637/jss.v042.i08.</Citation><ArticleIdList><ArticleId IdType="doi">10.18637/jss.v042.i08</ArticleId></ArticleIdList></Reference><Reference><Citation>Robin X, Turck N, Hainard A, et al. pROC: an open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinform. 2011;12:77. doi: 10.1186/1471-2105-12-77.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2105-12-77</ArticleId><ArticleId IdType="pmc">PMC3068975</ArticleId><ArticleId IdType="pubmed">21414208</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology. 1982;143:29&#x2013;36. doi: 10.1148/radiology.143.1.7063747.</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiology.143.1.7063747</ArticleId><ArticleId IdType="pubmed">7063747</ArticleId></ArticleIdList></Reference><Reference><Citation>Friedman JH, Hastie T, Tibshirani R. Regularization paths for generalized linear models via coordinate descent. J Stat Softw. 2010;33:1&#x2013;22. doi: 10.18637/jss.v033.i01.</Citation><ArticleIdList><ArticleId IdType="doi">10.18637/jss.v033.i01</ArticleId><ArticleId IdType="pmc">PMC2929880</ArticleId><ArticleId IdType="pubmed">20808728</ArticleId></ArticleIdList></Reference><Reference><Citation>Schafflick D, Xu CA, Hartlehnert M, et al. Integrated single cell analysis of blood and cerebrospinal fluid leukocytes in multiple sclerosis. Nat Commun. 2020;11:247. doi: 10.1038/s41467-019-14118-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-019-14118-w</ArticleId><ArticleId IdType="pmc">PMC6959356</ArticleId><ArticleId IdType="pubmed">31937773</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeltsch-David H, Muller S. Neuropsychiatric systemic lupus erythematosus: pathogenesis and biomarkers. Nat Rev Neurol. 2014;10:579&#x2013;596. doi: 10.1038/nrneurol.2014.148.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2014.148</ArticleId><ArticleId IdType="pubmed">25201240</ArticleId></ArticleIdList></Reference><Reference><Citation>Burbano C, Vasquez G, Rojas M. Modulatory effects of CD14+CD16++ monocytes on CD14++CD16- monocytes: a possible explanation of monocyte alterations in systemic lupus erythematosus. Arthritis Rheumatol. 2014;66:3371&#x2013;3381. doi: 10.1002/art.38860.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.38860</ArticleId><ArticleId IdType="pubmed">25168844</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu H, Hu F, Sun X, et al. CD16+ monocyte subset was enriched and functionally exacerbated in driving T-cell activation and B-cell response in systemic lupus erythematosus. Front Immunol. 2016;7:512. doi: 10.3389/fimmu.2016.00512.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2016.00512</ArticleId><ArticleId IdType="pmc">PMC5116853</ArticleId><ArticleId IdType="pubmed">27917174</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuriakose J, Redecke V, Guy C, et al. Patrolling monocytes promote the pathogenesis of early lupus-like glomerulonephritis. J Clin Invest. 2019;129:2251&#x2013;2265. doi: 10.1172/JCI125116.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI125116</ArticleId><ArticleId IdType="pmc">PMC6546471</ArticleId><ArticleId IdType="pubmed">31033479</ArticleId></ArticleIdList></Reference><Reference><Citation>Martinez J, Cunha LD, Park S, et al. Noncanonical autophagy inhibits the autoinflammatory, lupus-like response to dying cells. Nature. 2016;533:115&#x2013;119. doi: 10.1038/nature17950.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature17950</ArticleId><ArticleId IdType="pmc">PMC4860026</ArticleId><ArticleId IdType="pubmed">27096368</ArticleId></ArticleIdList></Reference><Reference><Citation>Mietzner B, Tsuiji M, Scheid J, et al. Autoreactive IgG memory antibodies in patients with systemic lupus erythematosus arise from nonreactive and polyreactive precursors. Proc Natl Acad Sci USA. 2008;105:9727&#x2013;9732. doi: 10.1073/pnas.0803644105.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0803644105</ArticleId><ArticleId IdType="pmc">PMC2474524</ArticleId><ArticleId IdType="pubmed">18621685</ArticleId></ArticleIdList></Reference><Reference><Citation>Tipton CM, Fucile CF, Darce J, et al. Diversity, cellular origin and autoreactivity of antibody-secreting cell expansions in acute systemic lupus erythematosus. Nat Immunol. 2015;16:755&#x2013;765. doi: 10.1038/ni.3175.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni.3175</ArticleId><ArticleId IdType="pmc">PMC4512288</ArticleId><ArticleId IdType="pubmed">26006014</ArticleId></ArticleIdList></Reference><Reference><Citation>Odendahl M, Jacobi A, Hansen A, et al. Disturbed peripheral B lymphocyte homeostasis in systemic lupus erythematosus. J Immunol. 2000;165:5970&#x2013;5979. doi: 10.4049/jimmunol.165.10.5970.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.165.10.5970</ArticleId><ArticleId IdType="pubmed">11067960</ArticleId></ArticleIdList></Reference><Reference><Citation>Biajoux V, Bignon A, Freitas C, et al. Expression of CXCL12 receptors in B cells from Mexican Mestizos patients with systemic lupus erythematosus. J Transl Med. 2012;10:251. doi: 10.1186/1479-5876-10-251.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1479-5876-10-251</ArticleId><ArticleId IdType="pmc">PMC3571925</ArticleId><ArticleId IdType="pubmed">23244336</ArticleId></ArticleIdList></Reference><Reference><Citation>Cepok S, Rosche B, Grummel V, et al. Short-lived plasma blasts are the main B cell effector subset during the course of multiple sclerosis. Brain. 2005;128:1667&#x2013;1676. doi: 10.1093/brain/awh486.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awh486</ArticleId><ArticleId IdType="pubmed">15800022</ArticleId></ArticleIdList></Reference><Reference><Citation>Alvermann S, Hennig C, St&#xfc;ve O, et al. Immunophenotyping of cerebrospinal fluid cells in multiple sclerosis: in search of biomarkers. JAMA Neurol. 2014;71:905&#x2013;912. doi: 10.1001/jamaneurol.2014.395.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2014.395</ArticleId><ArticleId IdType="pubmed">24818670</ArticleId></ArticleIdList></Reference><Reference><Citation>Stock AD, Der E, Gelb S, et al. Tertiary lymphoid structures in the choroid plexus in neuropsychiatric lupus. JCI Insight. 2019 doi: 10.1172/jci.insight.124203.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.124203</ArticleId><ArticleId IdType="pmc">PMC6629135</ArticleId><ArticleId IdType="pubmed">31167973</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>